* 从药明生物2269.HK分拆上市的中国药明合联2268.HK周四早盘跌幅扩大至5.3%。
* 同系公司药明康德603259.SS2359.HK此前公告称，4月1日继续出售所持有的药明合联5,080万股股票，成交金额约21.78亿港元，投资收益约为18.47亿元人民币。
* 药明合联今年迄今劲涨33.8%，同期恒生指数.HSI大幅上扬14.1%。
* 恒生香港上市生物科技指数.HSHKBIO盘中一度跌2.1%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 林高丽)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.